ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 437 filers reported holding ENCOMPASS HEALTH CORP in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,078,444 | +2675.9% | 130,840 | +3555.8% | 0.01% | – |
| Q1 2022 | $255,000 | -94.8% | 3,579 | -94.6% | 0.00% | -100.0% |
| Q3 2021 | $4,935,000 | +23.1% | 65,766 | +28.0% | 0.01% | 0.0% |
| Q2 2021 | $4,009,000 | -30.6% | 51,376 | -27.1% | 0.01% | -47.6% |
| Q1 2021 | $5,773,000 | -55.7% | 70,483 | -55.3% | 0.02% | -59.6% |
| Q4 2020 | $13,026,000 | +826.5% | 157,532 | +628.0% | 0.05% | +766.7% |
| Q3 2020 | $1,406,000 | +379.9% | 21,639 | +357.5% | 0.01% | +500.0% |
| Q2 2020 | $293,000 | -69.2% | 4,730 | -68.2% | 0.00% | -80.0% |
| Q1 2020 | $951,000 | +1967.4% | 14,854 | +2123.7% | 0.01% | – |
| Q4 2019 | $46,000 | -93.3% | 668 | -93.8% | 0.00% | -100.0% |
| Q3 2019 | $686,000 | -34.9% | 10,847 | -34.7% | 0.00% | -40.0% |
| Q2 2019 | $1,053,000 | +27.9% | 16,613 | +57.3% | 0.01% | -16.7% |
| Q3 2018 | $823,000 | – | 10,558 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |